XML 30 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Common Stock and Preferred Stock (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Summary of Warrants Outstanding

The following table summarizes information about shares issuable under warrants outstanding during the three months ended March 31, 2023:

   Warrant
shares
outstanding
  

Weighted
average
exercise

price

  

Weighted

average

remaining

life

  

Intrinsic

value

 
Outstanding at January 1, 2022   74,614,871   $0.05    4.47           - 
Issued   626,329,10    0.07    3.00    - 
Exercised   (18,380,379)   0.05    -    - 
Expired or cancelled   -    -    -    - 
Outstanding and exercisable at December 31, 2022   682,563,502    0.06    3.18    - 
Issued   12,666,572    -    -    - 
Exercised   (4,157,044)   0.05    -    - 
Expired or cancelled   -    -    -    - 
Outstanding and exercisable at March 31, 2023   691,073,030   $0.06    2.93   $- 

 

(*) Of the 12,666,572 and 626,329,010 shares issued during the three months ended March 31, 2023 and the year ended December 31, 2022, respectively and 682,563,502 and 691,073,030 shares outstanding and exercisable at March 31, 2023 and December 31, 2022, respectively, the weighted average exercise price and weighted average remaining life was not included for 616,195,582 and 603,529,010 warrants, respectively because their amount and exercise price is variable. The 12,666,572 warrants issued are a result of an adjustment to the number of X, Y and Z warrants as a result of the terms of the agreement. See Note 5 for the exercise prices of Series X, Y, and Z warrants. Series X, Y, and Z warrants expire on September 11, 2025.